Dopamine receptors in GtoPdb v.2023.1

Authors

  • Jean-Martin Beaulieu University of Toronto https://orcid.org/0000-0002-0446-7447
  • Emiliana Borrelli University of California Irvine
  • Arvid Carlsson University of Göteborg
  • Marc G. Caron Duke University
  • Olivier Civelli University of California, Irvine
  • Stefano Espinoza Istituto Italiano di Tecnologia
  • Gilberto Fisone Karolinska Institutet
  • Raul R. Gainetdinov St. Petersburg State University https://orcid.org/0000-0003-2951-6038
  • David K. Grandy Oregon Health & Science University
  • John W. Kebabian Research Biochemical Incorporated
  • Saloman Z. Langer Compugen
  • Maria Cristina Missale University of Brescia
  • Kim A. Neve Oregon Health & Science University
  • Bernard Scatton Sanofi Synthelabo Recherche
  • Jean-Charles Schwartz INSERM
  • Goran Sedvall Karolinska Institutet
  • Philip Seeman University of Toronto
  • David R. Sibley National Institutes of Health
  • Pierre Sokoloff INSERM
  • Pierre F. Spano Universitâ degli Studi di Brescia
  • Hubert H. M. Van Tol University of Toronto

DOI:

https://doi.org/10.2218/gtopdb/F20/2023.1

Abstract

Dopamine receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on Dopamine Receptors [373]) are commonly divided into D1-like (D1 and D5) and D2-like (D2, D3 and D4) families, where the endogenous agonist is dopamine.

Downloads

Published

26-Apr-2023

How to Cite

Beaulieu, J.-M. (2023) “Dopamine receptors in GtoPdb v.2023.1”, IUPHAR/BPS Guide to Pharmacology CITE, 2023(1). doi: 10.2218/gtopdb/F20/2023.1.

Issue

Vol. 2023 No. 1 (2023)

Section

Summaries